The legacy of Viagra offers a intricate case study for stakeholders eyeing drug companies. While early sales were remarkable, current patent lapse and the rise of cheaper versions have severely influenced earnings. https://joyceotsq422001.blogsmine.com/41344220/the-blue-pill-and-pharma-a-risky-stake